Our Q3 revenues came in at 26.9 MSEK compared to 26.0 in last year, up 3 % from last year. Currencies played a role and had a positive impact of 7MSEK for the first nine month. Our comparison quarter in 2021 was exceptionally strong due to one off bookings that was done during that quarter. […]
STOCKHOLM – 11 of August 2022 – ContextVision, a medical technology software company specializing in image processing, delivered the Company’s best ever second quarter revenue numbers and a significant EBITDA increase. Sales in the second quarter reached MSEK 32,5 (24.4), an 19% increase compared with the previous quarter, and an increase of 26% versus last year’s […]
The quarter saw a very strong progress with a revenue of 27,2MSEK (20,3) and an EBITDA of 9,2MSEK (9,8). “It has been an exciting quarter where we have been able to establish the new organization and fully focus on Medical Imaging business. During the quarter we signed both new customers as well as extended several […]
STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: For inquiries, please contact CFO Markus Hökerberg E-mail: ### About ContextVision ContextVision is a medical technology software company […]
STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK (94.7), which is the highest revenue in the history of the company. After a slow […]
ContextVision has decided to build its first fully digital pathology laboratory – thus confirming its strong dedication to advancing digitalization within pathology, for the best of both patients and the medical profession.
ContextVision delivered the Company’s best ever second quarter within Medical Imaging. Initial response from the ongoing clinical trials with the Company’s first digital pathology product, INIFY Prostate, are very promising.
ContextVision today reports its first quarter results for 2021. The quarter saw strong and promising progress within digital pathology and the company’s first product, INIFY Prostate Screening. While the ongoing pandemic slowed sales slightly, solid financials – paired with close dialogues with present and prospective clients – provide a positive outlook.
STOCKHOLM – April 7, 2021 – Please find ContextVision’s Annual Report 2020 and Remuneration Report 2020 attached. The reports can also be found on the company’s website: www.contextvision.se Printed copies of the reports will be distributed upon request by e-mail: For inquiries, please contact CFO Ann-Charlotte Linderoth E-mail: About ContextVision ContextVision is […]
ContextVision, today reports its fourth quarter and full year 2020 results. Total sales 2020 reached 94.7 MSEK (95.3), which matches the record year 2019 if adjusted for currency exchange effect – a solid achievement much related to a strong start of the year. Total EBITDA ends at 25.5 MSEK and operating result reached 15.5 MSEK.